Saira Ramasastry, Director at Mirum Pharmaceuticals, Inc. (MIRM), sold 2,000 shares at $96.90 ($194K) on 2026-04-15, disclosed to the SEC on 2026-04-16.
Scheduled sale ($194k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MIRM | SELL | 2026-03-17 | $182K | — | Filing → |
| MIRM | SELL | 2026-02-17 | $204K | — | Filing → |
| MIRM | SELL | 2026-01-16 | $182K | — | Filing → |